CN Stock MarketDetailed Quotes

002422 Sichuan Kelun Pharmaceutical

Watchlist
  • 30.86
  • -0.49-1.56%
Market Closed Sep 10 15:00 CST
49.43BMarket Cap17.33P/E (TTM)

Sichuan Kelun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Kelun Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.65B
5.61B
-42.55M
Miss Est.
+10.10%
+8.66%
-0.75%
Net Income
--
929.98M
--
+50.21%
Analyst Rating
Strong Buy

Sep 10, 2024

Sichuan Kelun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.815B--
--2024/Q3-- / 5.723B--
Aug 29, 20242024/Q25.608B / 5.650B--
Apr 25, 20242024/Q16.219B / 5.897B--
--2023/Q45.711B / 5.453B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.815B--
--2024/Q3-- / 5.723B--
Aug 29, 20242024/Q25.608B / 5.650B--
Apr 25, 20242024/Q16.219B / 5.897B--
--2023/Q45.711B / 5.453B--

Unlock Free Earnings Estimates

Sichuan Kelun Pharmaceutical Earnings Reports

  • Colon Pharmaceuticals: Semi-Annual Report 2024

    Aug 28 12:00 ET

  • Colon Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Sichuan Kelun Pharmaceutical: 2024 Half-Year Performance Bulletin

    Aug 12 12:00 ET

  • Colon Pharmaceuticals: First Quarter Report 2024

    Apr 24 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      92.31%

    • Buy

      7.69%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg